| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Glutamic Acid Decarboxylase-65 Antibody
Test CodeGAD-65
Quest Code
34878
Alias/See Also
GAD-65
GAD
Glutamic Acid Decarboxylase Auto Ab
GAD
Glutamic Acid Decarboxylase Auto Ab
CPT Codes
86341
Preferred Specimen
0.2 mL serum
Minimum Volume
0.1 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 60 days
Refrigerated: 14 days
Frozen: 60 days
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
Setup Schedule
Set up: Sun-Fri; Report available: 3-5 days
Limitations
GAD-65 antibodies are detected in 20% of diabetic twins who remain disease-free for long periods of time and in 8% of healthy individuals.
Reference Range
<5 IU/mL
Clinical Significance
Glutamic acid decarboxylase (GAD-65) antibody is useful to diagnose insulin dependent diabetes mellitus [Type I diabetes (autoimmune-mediated diabetes)] to assess risk for development of Type I diabetes, to predict onset of Type I diabetes, and risk of development of related endocrine disorders, e.g., thyroiditis. Before clinical onset, Type I diabetes is characterized by lymphocytic infiltration of the islet cells, and by circulating autoantibodies against a variety of islet cell antigens, including GAD-65, IA-2 (a tyrosine phosphatase-like protein), and insulin (IAA).
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153
Last Updated: September 17, 2019

